B7-H3 CAR-T for Recurrent or Refractory Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Recurrent Glioblastoma
Related studies linked through entity extraction aliases.
Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
CD147-CART Cells in Patients With Recurrent Malignant Glioma.
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab Plus SurVaxM for Glioblastoma at First Recurrence
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Study on the Treatment of Recurrent Glioblastoma With Anlotinib
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
IL13Ra2-CAR T Cells With or Without Nivolumab and Ipilimumab in Treating Patients With GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
- Status
- RECRUITING
- Phase
- PHASE1
Fimepinostat in Treating Brain Tumors in Children and Young Adults
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab
- Status
- TERMINATED
- Phase
- PHASE2
Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE2
TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE1
Feasibility of Individualized Therapy for Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Standard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment
- Status
- TERMINATED
- Phase
- PHASE1
Mathematical Model-Adapted Radiation In Glioblastoma
- Status
- COMPLETED
- Phase
- NA